Health News
Predicting Prostate Cancer's Return
The current most widely used test for detecting and monitoring prostate cancer, known as prostate specific antigen (PSA), has a lot of room for improvement for detecting new cancers.
The Busy Bees Fighting Cancer
There may be a some truth to the old naturalist belief that the answer to all of humanity's problems is out there somewhere, if we just knew where to look.
Using Light to Diagnose Cancer
Since the release of the new guidelines against using prostate specific antigen as a tool to screen for prostate cancer, the search for a more reliable way to identify patients at risk for prostate cancer has intensified.
E-vading Cancer
The anti-cancer benefits of vitamin E have been all over the map. Some studies say it increases a person's cancer risk; others suggest just the opposite. Scientists have hit a slick spot in this discussion.
Radiating Prostate Cancer
Between proton therapy, intensity-modulated radiation therapy ( IMRT ) and the older conformal radiation therapy, the three types of external radiation therapies used to treat prostate cancer differ slightly.
Biomarkers Differentiating Prostate Cancer
Abbott announced it has acquired an exclusive license for several novel biomarkers from Stanford University for use in developing a molecular diagnostic test that could satisfy a longstanding unmet medical need: differentiating aggressive from nonaggressive prostate cancer.
Predicting Prostate Cancer Relapse
More and more studies are showing that the best treatment for a given type of cancer may not be the same for everybody. A new study looking at prostate cancer adds to the growing amount of evidence supporting individualized treatment.
Prostate Cancer One-Ups Warren Buffett
One of the world's best business men and investors, Warren Buffet, has announced that he has early prostate cancer.
Metastasis Free Prostate Cancer Drug
One of the largest risks of cancer development is metastasis. A new prostate cancer drug in early stages of development has shown the ability to shut down metastasis entirely.
Predicting Prostate Cancer Aggressiveness
Genetic defects - mutations, rearrangements, too many copies, etc. - play a role in the development of cancer. Finding these faulty genes can predict risk. Recent research takes risk prediction a step further.